science

Hong Kong authorises Sinovac Covid vaccine for children aged 3 to 17


Hong Kong has approved lowering the age limit for the Covid-19 vaccine from China’s Sinovac Biotech to three years old, down from 18 years of age.

Sophia Chan, Hong Kong’s secretary for food and health, said in a statement published on Saturday: “Adolescents aged 12 to 17 will be accorded priority to receive the CoronaVac vaccine, with a view to extending to children of a younger age group at a later stage.”.

According to the statement, Chan considered that the benefits of approving the extension of the age eligibility to cover those aged three to 17 outweighed the risks.

A Hong Kong government advisory panel on Covid vaccines had earlier recommended that the minister approve the new age limit, the statement added.

The extension of the age eligibility comes as the vaccination campaign in the Asian financial hub which started in February has lagged behind many other developed economies. About 67% of the population are vaccinated with two shots from either Sinovac or Germany’s BioNTech.

In a separate statement on Friday, the city’s government said it had purchased 1m extra doses of BioNTech vaccine for third dose Covid vaccinations.

Hong Kong has followed Beijing’s lead in retaining strict travel restrictions to curb new outbreaks, in contrast to a global trend of opening up and living with the coronavirus.

International business lobby groups have warned that Hong Kong could lose talent and investment, as well as competitive ground to rival finance hubs such as Singapore, unless it relaxes its restrictions on travel.

Despite barely any recent local cases and an environment virtually free of Covid, Hong Kong has imposed mandatory hotel quarantine of up to 21 days for arrivals from most countries at the travellers’ cost.



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more